FY2025 revenue ¥1.01tn (+1.3%); operating margin 9.6%; net income ¥68.2bn.
Balance sheet figures not captured from release.
Showing 1–14 of 14
FY2025 revenue ¥1.01tn (+1.3%); operating margin 9.6%; net income ¥68.2bn.
Balance sheet figures not captured from release.
FY2025 revenue $260.2m (+53.0%); operating margin -4.6%; net loss $12.8m.
No debt; $222.0m cash.
FY2025 revenue $1.18bn (+6.5%); operating margin 0.4%; net income $2.1m.
Cash $196.5m; debt $167.6m.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Parent UnitedHealth Group (UNH) group FY2025 revenue $447.57bn (+11.8%); operating margin 4.2%; net income $12.06bn.
Optum: revenue $270.6bn (+7%), earnings from operations $9.5bn.
Parent Oracle (ORCL) group FY2026 revenue $67.36bn (+17.0%); operating margin 30.6%; net income $17.09bn.
Figures cover the whole listed group, not this business alone.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue SEK 73.4m (-8.7%); net loss SEK 21.9m.
EBITDA SEK -15.9m; raised about SEK 52m in a rights issue.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
FY2025 revenue £223.9m (+22.2%); operating margin -69.4%; net loss £145.2m.
No debt; £302.8m cash.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.